Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pLP-LNCX-PIK3CA-H1047R Citations (2)

Originally described in: Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA.
Kim JS, Lee C, Bonifant CL, Ressom H, Waldman T Mol Cell Biol. 2007 Jan . 27(2):662-77. PubMed Journal

Articles Citing pLP-LNCX-PIK3CA-H1047R

Articles
Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers. Thomas C, Henry W, Cuiffo BG, Collmann AY, Marangoni E, Benhamo V, Bhasin MK, Fan C, Fuhrmann L, Baldwin AS, Perou C, Vincent-Salomon A, Toker A, Karnoub AE. Sci Signal. 2017 Feb 21;10(467). pii: 10/467/eaah4674. doi: 10.1126/scisignal.aah4674. PubMed
Combinatorial CRISPR/Cas9 Screening Reveals Epistatic Networks of Interacting Tumor Suppressor Genes and Therapeutic Targets in Human Breast Cancer. Zhao X, Li J, Liu Z, Powers S. Cancer Res. 2021 Dec 15;81(24):6090-6105. doi: 10.1158/0008-5472.CAN-21-2555. Epub 2021 Sep 24. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.